Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Positively charged extracellular proteins represent a functional class of proteins characterized by high isoelectric points, enabling them to interact electrostatically with negatively charged components of the extracellular environment, such as glycosaminoglycans (GAGs), heparan sulfate, and extracellular DNA (eDNA). This group encompasses a wide range of molecules, including growth factors (e.g., FGF, VEGF), chemokines, degradative enzymes (e.g., elastase, hyaluronidase), and cytotoxic proteins released during cell death, most notably extracellular histones. In physiological conditions, these proteins are essential for organizing the extracellular matrix (ECM) and regulating signaling gradients. However, their dysregulated release or overabundance is a hallmark of various diseases, including sepsis, where extracellular histones act as major mediators of systemic inflammation and organ failure. Therapeutic targeting of this class typically involves the use of polyanionic drugs like pentosan polysulfate sodium or non-anticoagulant heparinoids (e.g., STC3141), which bind and neutralize these cationic proteins to prevent their pro-inflammatory and tissue-damaging effects.
Electrostatic binding and neutralization of cationic proteins to inhibit pro-inflammatory signaling, sequester growth factors, and prevent enzymatic degradation of the extracellular matrix.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Positively charged extracellular proteins.